Accrued Expense	6 Months Ended
Jun. 30, 2012
Accrued Expense	5. Accrued Expense As of June 30, 2012, Current Liabilities included accrued expense of $86,588. This includes approximate amounts for accrued expenses of $6,000 for legal fees, stock transfer fees of $2,900, expenses reports totaling $5,000 and management bonus accrual totaling $69,000. As of June 30, 2012, Current Liabilities also included accrued expense related party consisting of $52,700 for clinical trial R&D hospital expenses related to MD Anderson treating patients in the Phase I clinical trial (see Note 2.).

Accrued Expense

6 Months Ended

Jun. 30, 2012

5. Accrued Expense

As of June 30, 2012, Current Liabilities included accrued expense of $86,588. This includes approximate amounts for accrued expenses of $6,000 for legal fees, stock transfer fees of $2,900, expenses reports totaling $5,000 and management bonus accrual totaling $69,000. As of June 30, 2012, Current Liabilities also included accrued expense related party consisting of $52,700 for clinical trial R&D hospital expenses related to MD Anderson treating patients in the Phase I clinical trial (see Note 2.).